Clinical Guidelines: Managing GI Side Effects of GLP-1 Meds An expert panel comprising of physicians, cardiologists, endocrinologists, nurses, diabetes nurse educators and nephrologists released clinical guidelines to help manage the GI side effects of GLP-1 medications
Bezin J, Gouverneur A, Penichon M, Mathieu C, Garrel R, Hillaire-Buys D, et al
For Research Use Only Summary Ipamorelin is a highly selective growth hormone secretagogue researched for its potential role in growth hormonerelease signaling, recovery-focused physiological pathways, sleep-quality research, and tissue-repair pathways
The inclusion criteria for this cross over trial were: Male or female patients with confirmed HIV-1 infection (ELISA antibody testing), a stable antiretroviral combination that remained unchanged throughout the study, a clinical diagnosis of antiretroviral toxic neuropathy, and ALCAR therapy (1.5 g twice daily) for at least 3 months
T2DM remains one of the most prevalent chronic conditions worldwide, driving demand for effective and convenient treatment options
Why weight loss isnt the whole explanation Weight loss absolutely improves heart health: it can lower blood pressure, improve cholesterol patterns, and reduce strain on the heart